Thu, October 13, 2011
[ Thu, Oct 13th 2011 ] - Market Wire
Trimel Appoints John Friedrichsen to Its Board of Director
[ Thu, Oct 13th 2011 ] - Market Wire
Amica Mature Lifestyles to Announce First Quarter .. esults and Host Conference Call November 14, 2011
[ Thu, Oct 13th 2011 ] - Market Wire
Vanguard Health Systems Appoints Former Tennessee Governor to Board of Directors
[ Thu, Oct 13th 2011 ] - Market Wire
Synageva BioPharma and Trimeris Announce Special Meetings of Stockholders to Approve Merger
[ Thu, Oct 13th 2011 ] - Market Wire
Mercka?s ISENTRESS® (raltegravir) in Combination .. cal and Immunological Efficacy Versus the Efavire
[ Thu, Oct 13th 2011 ] - Market Wire
Micromet Obtains FDA Feedback on Registration Strategy for Blinatumomab in Relapsed/Refractory ALL
[ Thu, Oct 13th 2011 ] - Market Wire
Horizon Pharma Receives U.S. Patent Allowance for DUEXIS(R) in the United States
[ Thu, Oct 13th 2011 ] - Market Wire
U.S. Sales of EGRIFTA(R) Driving Revenue Growth
[ Thu, Oct 13th 2011 ] - Market Wire
Los datos presentados durante el 5 Congreso trien .. or ECTRIMS y ACTRIMS demuestran el compromiso y l
[ Thu, Oct 13th 2011 ] - Market Wire
ISTA Pharmaceuticals Reports Results From the Sec .. URA(TM) Phase 3 Clinical Program for Dry Eye Dise
[ Thu, Oct 13th 2011 ] - Market Wire
China Medical Technologies Receives SFDA Approval .. ed KRAS Assay for Colorectal Cancer Targeted Drug
Wed, October 12, 2011
[ Wed, Oct 12th 2011 ] - Market Wire
Financial Statement 10/11
[ Wed, Oct 12th 2011 ] - Market Wire
Mylan Announces Intention to Refinance Existing Secured Credit Facility
[ Wed, Oct 12th 2011 ] - Market Wire
Dynavax to Host Analyst &;; Investor Day Webcast October 27, 2011
[ Wed, Oct 12th 2011 ] - Market Wire
Analyst View, Impact of Global Events - Research .. n Pharmaceuticals, Inc. and Trustmark Corporation
[ Wed, Oct 12th 2011 ] - Market Wire
Implant Sciences Receives Orders for the QS-B220 .. ench-Top Explosives and Narcotics Trace Detectors
[ Wed, Oct 12th 2011 ] - Market Wire
Ceapro Announces Signing of a Sales Agreement Wit .. s Inc. for its certified All-Natural Active Ingre
[ Wed, Oct 12th 2011 ] - Market Wire
OPKO Completes Sale of Ophthalmic Instrumentation Business
[ Wed, Oct 12th 2011 ] - Market Wire
Data Presented at the 5th Joint Triennial Congres .. nstrates Biogen Ideca?s Novel Science and Commitm
[ Wed, Oct 12th 2011 ] - Market Wire
Study Supports Use of Cambridge Hearta?s MTWA Test as Predictor of Sudden Cardiac Death
[ Wed, Oct 12th 2011 ] - Market Wire
SciClone Pharmaceuticals Announces Preliminary Settlement of Stockholder Derivative Litigation
[ Wed, Oct 12th 2011 ] - Market Wire
Illumina Announces Novel Human Exome Content Available on Multiple BeadChip Formats
Tue, October 11, 2011
[ Tue, Oct 11th 2011 ] - Market Wire
Luminex Corporation Third Quarter Earnings Release Scheduled for November 1, 2011
[ Tue, Oct 11th 2011 ] - Market Wire
Molina Healthcare of Missouri Receives aCommendablea? NCQA Status
[ Tue, Oct 11th 2011 ] - Market Wire
St. Jude Medical verbessert sein Patientenfernber .. gssystem durch mobile Benachrichtigungsfunktionen
[ Tue, Oct 11th 2011 ] - Market Wire
Healthnostics Launching MicroFill-2160 1st Quarter 2012
[ Tue, Oct 11th 2011 ] - Market Wire
GlycoMimetics and Pfizer Enter into Licensing Agr .. rently in Development to Treat Patients Experienc
[ Tue, Oct 11th 2011 ] - Market Wire
Glamsmile Opens Rome Studio, With the Wenzhou Studio Opening to Follow Shortly Thereafter
[ Tue, Oct 11th 2011 ] - Market Wire
International Stem Cell's Research Scientists Suc .. t Series of Preclinical Animal Trials of Neuronal
[ Tue, Oct 11th 2011 ] - Market Wire
BioSante Pharmaceuticals Reports Positive LibiGel® Safety Data Review in Phase III Program
[ Tue, Oct 11th 2011 ] - Market Wire
Breakthrough in Multiple Sclerosis Achieved by FO .. IGHT MRI Announced at UC San Diego Medical Center
[ Tue, Oct 11th 2011 ] - Market Wire
Aetna??Michael Elliott???????
[ Tue, Oct 11th 2011 ] - Market Wire
Illumina Introduces Revolutionary Workflow Enhancements for MiSeqa"
Mon, October 10, 2011
[ Mon, Oct 10th 2011 ] - Market Wire
Electromed, Inc. Introduces aSeriously Pinka to Its SmartVest® Product Line
[ Mon, Oct 10th 2011 ] - Market Wire
Magellan Health Services Announces New Pharmacy Organization
[ Mon, Oct 10th 2011 ] - Market Wire
Health Net Receives Full URAC Accreditation for Disease Management
[ Mon, Oct 10th 2011 ] - Market Wire
Innovative Pipelines From Avanir and Cyclacel Pharmaceuticals Gain Momentum
[ Mon, Oct 10th 2011 ] - Market Wire
Equity Research on Humana Inc. and WellPoint Inc. - Obamacare Helping Several Health Insurers
[ Mon, Oct 10th 2011 ] - Market Wire
St. Jude Medical Advances Its Remote Patient Monitoring System with Mobile Notifications
[ Mon, Oct 10th 2011 ] - Market Wire
Ligand Enters Into Global Licensing Agreement With Chiva Pharmaceuticals for Fablyn®
[ Mon, Oct 10th 2011 ] - Market Wire
Natus Medical Announces Preliminary 2011 Third Quarter Revenue Results
[ Mon, Oct 10th 2011 ] - Market Wire
Medtronic Announces Results from TTOP-AF Trial De .. of Its Phased RF Ablation System in Treating Per
[ Mon, Oct 10th 2011 ] - Market Wire
PAREXEL and National University of Singapore Esta .. Meet Increasing Demand in Asia for Clinical Rese
[ Mon, Oct 10th 2011 ] - Market Wire
Inovio Pharmaceuticals and VGX International to A .. C and Hepatitis B Synthetic Vaccines into Clinica
Sun, October 9, 2011
[ Sun, Oct 09th 2011 ] - Market Wire
Watson Provides Update on District Court Order Concerning Generic Version of LOVENOX®
[ Sun, Oct 09th 2011 ] - Market Wire
Mylan Comments on Death of Company Co-Founder and Former Chairman and CEO Milan "Mike" Puskar
Sat, October 8, 2011
[ Sat, Oct 08th 2011 ] - Market Wire
FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. ;;;;;;; a Once-Daily Therap
[ Sat, Oct 08th 2011 ] - Market Wire
FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. Daily Therapy for Patients with Type 2 Diabetes W
[ Sat, Oct 08th 2011 ] - Market Wire
FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. 9;; a Once-Daily Therapy for Patients with
[ Sat, Oct 08th 2011 ] - Market Wire
FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. ;;; a Once-Daily Therapy for Patients w
[ Sat, Oct 08th 2011 ] - Market Wire
FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. e-Daily Therapy for Patients with Type 2 Diabetes
[ Sat, Oct 08th 2011 ] - Market Wire
KCI Announces Proposed Offering of Senior Notes
[ Sat, Oct 08th 2011 ] - Market Wire
Watson Confirms District Court Order Concerning Generic Version of LOVENOX(R)
[ Sat, Oct 08th 2011 ] - Market Wire
West Increases Quarterly Dividend to $0.18
[ Sat, Oct 08th 2011 ] - Market Wire
Amerigroup Enhances Maternal Outreach Efforts
[ Sat, Oct 08th 2011 ] - Market Wire
IBM Launches University Competition to Combat Growth of Non-Communicable Diseases
Fri, October 7, 2011
[ Fri, Oct 07th 2011 ] - Market Wire
Celgene publica nueva informacin adicional sobre la conclusin del Artculo 20 para REVLIMID®
[ Fri, Oct 07th 2011 ] - Market Wire
NuVasive Completes Acquisition of Impulse Monitor .. and Conference Call of Third Quarter 2011 Results
[ Fri, Oct 07th 2011 ] - Market Wire
Law Offices of Howard G. Smith LLP Continues Inve .. ation of Pharmaceutical Product Development, Inc.
[ Fri, Oct 07th 2011 ] - Market Wire
Akorn, Inc. Announces Third Quarter 2011 Earnings Release and Conference Call Information
[ Fri, Oct 07th 2011 ] - Market Wire
MEDNAX 2011 Third Quarter Conference Call/Webcast Scheduled for Tuesday, November 1, 2011
[ Fri, Oct 07th 2011 ] - Market Wire
Vertex Announces the Date of its Third Quarter 2011 Financial Results Conference Call and Webcast
[ Fri, Oct 07th 2011 ] - Market Wire
Cardiovascular Systems Announces Preliminary First-Quarter Financial Results
[ Fri, Oct 07th 2011 ] - Market Wire
Analyst View, Impact of Global Events - Research .. n MELA Sciences, Inc. and SIGA Technologies, Inc.
[ Fri, Oct 07th 2011 ] - Market Wire
Expert's Economic Outlook, Global - Equity Resear .. harmaceutical Companies, Inc. and Targacept, Inc.
[ Fri, Oct 07th 2011 ] - Market Wire
Adherex Reports Meeting With FDA's Pediatric Subc .. gs Advisory Committee on the Development of Sodiu
[ Fri, Oct 07th 2011 ] - Market Wire
Senetek Announces Work Plans at Iron Creek Project
Thu, October 6, 2011
[ Thu, Oct 06th 2011 ] - Market Wire
Hansen Medical Announces Settlement of SEC Investigation
[ Thu, Oct 06th 2011 ] - Market Wire
DiaMedica Named 2011 Emerging Company of the Year by Life Science Association of Manitoba
[ Thu, Oct 06th 2011 ] - Market Wire
Patient Home Monitoring Announces Unaudited Reven .. for September 2011, and Growth Figures for Q4 20
[ Thu, Oct 06th 2011 ] - Market Wire
Equity Research on Gilead Sciences Inc. and Human .. . - Regulatory Approval Key for Biotech Companies
[ Thu, Oct 06th 2011 ] - Market Wire
Peregrine Completes Patient Enrollment in Second- .. er Trial;; Data to Be Unblinded in First H
[ Thu, Oct 06th 2011 ] - Market Wire
Trimel Provides Update on Female Sexual Dysfunction "Anorgasmia" Clinical Program
[ Thu, Oct 06th 2011 ] - Market Wire
Novadaq Reports 165 System Shipments During Third Quarter 2011
[ Thu, Oct 06th 2011 ] - Market Wire
Threshold Pharmaceuticals to Present at the BioCentury NewsMakers Conference
[ Thu, Oct 06th 2011 ] - Market Wire
Alexza and Grupo Ferrer Establish Partnership for .. uvea" (Staccato® Loxapine) in Europe and Latin A
[ Thu, Oct 06th 2011 ] - Market Wire
Greystone Logistics Announces Record Sales in 4th Quarter
[ Thu, Oct 06th 2011 ] - Market Wire
The Ensign Group Acquires La Jolla Skilled Nursing Facility
Wed, October 5, 2011
[ Wed, Oct 05th 2011 ] - Market Wire
Basilea receives request for extraordinary shareh .. lect additional members to the board of directors
[ Wed, Oct 05th 2011 ] - Market Wire
Waters Empowers Advantar Laboratories for Sustained Growth
[ Wed, Oct 05th 2011 ] - Market Wire
Investigational Oral Multiple Sclerosis Therapy T .. ignificantly Reduced Relapse Rate, Disability Pro
[ Wed, Oct 05th 2011 ] - Market Wire
MURRAY FRANK LLP Announces Investigation of Pharmaceutical Product Development, Inc.
[ Wed, Oct 05th 2011 ] - Market Wire
Law Office of Brodsky & Smith, LLC Announces Investigation of DaVita, Inc.
[ Wed, Oct 05th 2011 ] - Market Wire
Voclosporin study published in the American Journal of Transplantation
[ Wed, Oct 05th 2011 ] - Market Wire
OncoSec Releases Devices for Use in Clinical Trials
[ Wed, Oct 05th 2011 ] - Market Wire
Inovio Pharmaceuticals' Synthetic Vaccine for Can .. ost Promising Research at Global Vaccine Congress
Tue, October 4, 2011
[ Tue, Oct 04th 2011 ] - Market Wire
Law Offices of Howard G. Smith LLP Announces Inve .. ation of Pharmaceutical Product Development, Inc.
[ Tue, Oct 04th 2011 ] - Market Wire
Bronstein, Gewirtz & Grossman, LLC Investigates DaVita, Inc.
[ Tue, Oct 04th 2011 ] - Market Wire
POZEN Provides Patent Litigation and Financial Guidance Update
[ Tue, Oct 04th 2011 ] - Market Wire
Faruqi & Faruqi, LLP Announces Investigation of Pharmaceutical Product Development Inc.
[ Tue, Oct 04th 2011 ] - Market Wire
Ryan & Maniskas, LLP Announces Investigation of Pharmaceutical Product Development Inc.
[ Tue, Oct 04th 2011 ] - Market Wire
Neurocrine Biosciences Receives Second Milestone .. $20 Million Under Abbott Collaboration Agreement
[ Tue, Oct 04th 2011 ] - Market Wire
Investigation of Pharmaceutical Product Developme .. oldfarb Branham Law Firm LLP for Potential Shareh
[ Tue, Oct 04th 2011 ] - Market Wire
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
[ Tue, Oct 04th 2011 ] - Market Wire
Initial Data from Bio-Path Holdingsa? Phase I Cli .. entation at American Society of Hematology Annual
Mon, October 3, 2011
[ Mon, Oct 03rd 2011 ] - Market Wire
Law Office of Brodsky & Smith, LLC Announces Inve .. tion of Pharmaceuticals Product Development, Inc.
[ Mon, Oct 03rd 2011 ] - Market Wire
Por segundo ao consecutivo, el Humana Walmart-Pre .. a prima mensual ms baja en los 50 estados y en Wa
[ Mon, Oct 03rd 2011 ] - Market Wire
Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2011 Results
[ Mon, Oct 03rd 2011 ] - Market Wire
The Law Firm of Levi & Korsinsky, LLP Announces Investigation of American Medical Alert Corp.
[ Mon, Oct 03rd 2011 ] - Market Wire
The Law Firm of Levi & Korsinsky, LLP Announces I .. ation of Pharmaceutical Product Development, Inc.
[ Mon, Oct 03rd 2011 ] - Market Wire
Tripp Levy PLLC Announces Investigation of Pharmaceutical Product Development
[ Mon, Oct 03rd 2011 ] - Market Wire
The Briscoe Law Firm and Powers Taylor, LLP Annou .. ation of Pharmaceutical Product Development, Inc.
[ Mon, Oct 03rd 2011 ] - Market Wire
Rigrodsky & Long, P.A. Announces Investigation of Pharmaceutical Product Development, Inc.
[ Mon, Oct 03rd 2011 ] - Market Wire
Medwell Capital to Adopt IFRS
[ Mon, Oct 03rd 2011 ] - Market Wire
IMRIS Announces Retirement of Chief Operating Officer
[ Mon, Oct 03rd 2011 ] - Market Wire
Allegiance Completes Private Placement Of 229,166 Common At $0.48 Per Share
Sun, October 2, 2011
[ Sun, Oct 02nd 2011 ] - Market Wire
HeartWare Reports Additional Clinical Data From B .. nued Access Patients at the 25th European Associa
Sat, October 1, 2011
[ Sat, Oct 01st 2011 ] - Market Wire
HealthSpring Unveils 2012 Medicare Advantage Plans
Fri, September 30, 2011
[ Fri, Sep 30th 2011 ] - Market Wire
Sangamo BioSciences to Host Conference Call to Di .. m Phase 2b Trial of SB-509 in Diabetic Neuropathy
[ Fri, Sep 30th 2011 ] - Market Wire
AxoGen, Inc. Announces Completion of Merger, Name Change and Executive Team Changes
[ Fri, Sep 30th 2011 ] - Market Wire
Health Management Associates, Inc. Completes the .. alth Partners from Catholic Health Partners, Inc.
[ Fri, Sep 30th 2011 ] - Market Wire
Merck Announces New Data Analyses for VICTRELISa" .. ed at The American Association for the Study of L
[ Fri, Sep 30th 2011 ] - Market Wire
Vertex to Present New Data from Hepatitis C Development Program at AASLD Annual Meeting
[ Fri, Sep 30th 2011 ] - Market Wire
Reminding Seniors to Be Mindful of Medications
[ Fri, Sep 30th 2011 ] - Market Wire
Merck to Hold Third-Quarter 2011 Sales and Earnings Conference Call on October 28
[ Fri, Sep 30th 2011 ] - Market Wire
Pfizer Reports Top-Line Results Of A Phase 3 Clin .. acy And Safety Of VFEND® (voriconazole) And ERAX
[ Fri, Sep 30th 2011 ] - Market Wire
A Randomized Phase 2 Study of Selumetinib in Patients with KRAS-Mutant Non-Small Cell Lung Cancer
[ Fri, Sep 30th 2011 ] - Market Wire
ShangPharma to Attend Upcoming Investor Conferences in October
[ Fri, Sep 30th 2011 ] - Market Wire
Concord Medical Services Announces Share Repurchase Program
Thu, September 29, 2011
[ Thu, Sep 29th 2011 ] - Market Wire
Boston Scientific Begins Enrollment in NECTAR-HF Clinical Trial
[ Thu, Sep 29th 2011 ] - Market Wire
Biogen Idec bevordert Tony Kingsley tot hoofd van Global Commercial Operations
[ Thu, Sep 29th 2011 ] - Market Wire
Aetna to Offer Individual Products to the National Association for the Self Employed
[ Thu, Sep 29th 2011 ] - Market Wire
Galectin Therapeutics Posts New Corporate Presentation Video to its Website
[ Thu, Sep 29th 2011 ] - Market Wire
SANUWAVE Appoints Private Equity Veteran Barbara M. Henagan to Its Board of Directors
[ Thu, Sep 29th 2011 ] - Market Wire
Representative Brian Bilbray Meets with Internati .. Stem Cell Executives to Discuss Research Funding
[ Thu, Sep 29th 2011 ] - Market Wire
The National Association Of Boards Of Pharmacy An .. Patients About The Flood Of Counterfeit Medicines
[ Thu, Sep 29th 2011 ] - Market Wire
Federal Fire Department in Pearl Harbor Uses ZOLL .. ave 37-Year-Old Seaman from Sudden Cardiac Arrest
[ Thu, Sep 29th 2011 ] - Market Wire
NanoViricides Inc Files For Extension of Form 10-K Annual Report Submission Date
[ Thu, Sep 29th 2011 ] - Market Wire
Illumina Introduces Low-Cost Bovine BeadChip for Genotyping of Dairy Cattle
[ Thu, Sep 29th 2011 ] - Market Wire
Chronic Conditions Cost UK Economy More Than 20 Billion Pounds a Year
Wed, September 28, 2011
[ Wed, Sep 28th 2011 ] - Market Wire
Five Days Remain before Deadline in Class-action Lawsuit against Dendreon, Says Hagens Berman
[ Wed, Sep 28th 2011 ] - Market Wire
HeartWare Announces Presentation of Clinical Data .. tion for Cardio-Thoracic Surgery (EACTS) Annual M
[ Wed, Sep 28th 2011 ] - Market Wire
BioDelivery Sciences Announces Results from Phase .. cacy Study for BEMA Buprenorphine in Chronic Pain
[ Wed, Sep 28th 2011 ] - Market Wire
Experts to Provide Successful Strategies for Glob .. ent and Commercialization at PAREXEL Tokyo Semina
[ Wed, Sep 28th 2011 ] - Market Wire
Boston Scientific Announces Favorable Appellate C .. ming Non-Infringement of Johnson & Johnson Patent
[ Wed, Sep 28th 2011 ] - Market Wire
Merck Sells Its Interest in Johnson & Johnson-Merck Consumer Pharmaceuticals
[ Wed, Sep 28th 2011 ] - Market Wire
IntegraMed Promotes Tim Sheehan to SVP and CFO
[ Wed, Sep 28th 2011 ] - Market Wire
ImmunoCellular Therapeuticsa? ICT-107 Recognized .. hovera?s Top 10 Most Licensable Oncology Products
[ Wed, Sep 28th 2011 ] - Market Wire
Amyris e Michelin Anunciam Colaborao para Desenvolver e Comercializar Isopreno de Fontes Renovveis
Tue, September 27, 2011
[ Tue, Sep 27th 2011 ] - Market Wire
Gallup und Healthways verffentlichen erste Ergebn .. s Well-Being (Wohlbefindens)-Index fr Deutschland
[ Tue, Sep 27th 2011 ] - Market Wire
HCA Announces Proposed Public Offering of $500 Million Senior Notes
[ Tue, Sep 27th 2011 ] - Market Wire
Medtronic Announces Start of Pivotal Trial for En .. TM Transcatheter Aortic Valve Implantation System
[ Tue, Sep 27th 2011 ] - Market Wire
Catasys Launches Its Integrated Substance Dependence Program in Massachusetts
[ Tue, Sep 27th 2011 ] - Market Wire
Merck Names Cuong Viet Do as Chief Strategy Officer
[ Tue, Sep 27th 2011 ] - Market Wire
POZEN Announces October 4, 2011 Mid-Quarter Update and Financial Guidance Webcast
[ Tue, Sep 27th 2011 ] - Market Wire
BioLineRx to Present Data from the Successfully C .. L-1020 at European Conference on Schizophrenia Re
[ Tue, Sep 27th 2011 ] - Market Wire
Gallup, Healthways Release Inaugural Well-Being Index Results for Germany
[ Tue, Sep 27th 2011 ] - Market Wire
Molina Healthcare Names Michael Steele as Senior Vice President of Dual Eligible Strategies
[ Tue, Sep 27th 2011 ] - Market Wire
Alexion recibe opinin positiva del CHMP para Soli .. s con sndrome ur©mico hemoltico atpico (aHUS) en
[ Tue, Sep 27th 2011 ] - Market Wire
Evidence of AT13387 Activity in Gastrointestinal Stromal Tumor Models Presented at ECCO
Mon, September 26, 2011
[ Mon, Sep 26th 2011 ] - Market Wire
The Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of American Medical Alert Corp.
[ Mon, Sep 26th 2011 ] - Market Wire
Guidance For Cannabis Science Brand Products To B .. lorado Based On Accumulating Anecdotal Reports Of
[ Mon, Sep 26th 2011 ] - Market Wire
Health Net Sponsors 2011 Congressional Medal of Honor Convention and Star-Studded Tribute Concert
[ Mon, Sep 26th 2011 ] - Market Wire
NPS Pharmaceuticals Appoints Eric Pauwels as Chief Commercial Officer
[ Mon, Sep 26th 2011 ] - Market Wire
Alnylam Initiates Phase I Clinical Study of ALN-P .. ting PCSK9 for the Treatment of Severe Hyperchole
[ Mon, Sep 26th 2011 ] - Market Wire
Synta Announces Presentation of Results of Ganete .. udy in Combination with Docetaxel in Solid Tumors
[ Mon, Sep 26th 2011 ] - Market Wire
iCo Therapeutics and JDRF Partner to Investigate iCo-007 in Diabetic Macular Edema
[ Mon, Sep 26th 2011 ] - Market Wire
ARIAD Announces Long-Term Follow Up of Patients w .. stant CML Treated with Ponatinib in Phase 1 Trial
[ Mon, Sep 26th 2011 ] - Market Wire
Millennium y Seattle Genetics presentan datos cln .. uximab Vedotin) en pacientes peditricos en reunin
[ Mon, Sep 26th 2011 ] - Market Wire
National Hospice and Palliative Care Expert Joins Amedisys
Sat, September 24, 2011
[ Sat, Sep 24th 2011 ] - Market Wire
FDA lsst Soliris® (Eculizumab) zur Behandlung al .. atypischem hmolytisch-urmischem Syndrom (aHUS) zu
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium en Seattle Genetics presenteren klinis .. brentuximab vedotin) bij pediatrische patinten op
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium e Seattle Genetics presentano dati cli .. ab vedotin) nei pazienti pediatrici all'&
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium e Seattle Genetics presentano dati cli .. ab vedotin) nei pazienti pediatrici all'&
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium et Seattle Genetics pr©sentent, la?oc .. de la?EMCC, des donn©es cliniques concernant la?
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium und Seattle Genetics legen auf der EMC .. n zu ADCETRISa" (Brentuximab Vedotin) bei pdiatri
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium et Seattle Genetics pr©sentent la?occ .. e la?EMCC des donn©es cliniques concernant la?ut
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium et Seattle Genetics pr©sentent, .. r©union annuelle de la?EMCC,;;; des
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium et Seattle Genetics pr©sentent, .. occasion de la r©union annuelle de la?EMCC,&#
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium and Seattle Genetics Present Clinical .. mab Vedotin) in Pediatric Patients at EMCC Annual
Fri, September 23, 2011
[ Fri, Sep 23rd 2011 ] - Market Wire
CytoDyn Announces Humanized Cytolin® Provisional .. t Application Filed for the Treatment of HIV/AIDS
[ Fri, Sep 23rd 2011 ] - Market Wire
Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Allos Therapeutics, Inc.
[ Fri, Sep 23rd 2011 ] - Market Wire
Soliris (eculizumab) goedgekeurd door FDA voor al .. met atypisch hemolytisch uremisch syndroom (aHUS)
[ Fri, Sep 23rd 2011 ] - Market Wire
Celgene: reglementaire update inzake REVLIMID
[ Fri, Sep 23rd 2011 ] - Market Wire
Glancy Binkow & Goldberg LLP Announces Investigation of American Medical Alert Corp.
[ Fri, Sep 23rd 2011 ] - Market Wire
European CHMP Adopts Positive Opinion for Evipler .. Tablet Regimen for the Treatment of HIV Infection
[ Fri, Sep 23rd 2011 ] - Market Wire
MISE JOUR RGLEMENTAIRE DE CELGENE AU SUJET DE REVLIMID®
[ Fri, Sep 23rd 2011 ] - Market Wire
Celgene prsentiert aktuelle Informationen zur Marktzulassung von REVLIMID®
[ Fri, Sep 23rd 2011 ] - Market Wire
AGGIORNAMENTO REGOLATORIO DI CELGENE CIRCA REVLIMID®
[ Fri, Sep 23rd 2011 ] - Market Wire
Celgene Regulatory Update on REVLIMID®
Thu, September 22, 2011
[ Thu, Sep 22nd 2011 ] - Market Wire
Covidien anuncia un aumento de dividendos del 12,5%
[ Thu, Sep 22nd 2011 ] - Market Wire
Enzon Announces Reduction in Force to Align Operations with Research and Development Activities
[ Thu, Sep 22nd 2011 ] - Market Wire
U.S. Physical Therapy to Present at the The Sixth Annual JMP Securities Healthcare Conference
[ Thu, Sep 22nd 2011 ] - Market Wire
Brain Resource Opens U.S. Headquarters in San Francisco
[ Thu, Sep 22nd 2011 ] - Market Wire
PFCD Hill Briefing Demonstrates How Health Indices Promote Prevention and Improve Overall Health
[ Thu, Sep 22nd 2011 ] - Market Wire
Law Office of Brodsky & Smith, LLC Announces Class Action Lawsuit Against Dendreon Corporation
[ Thu, Sep 22nd 2011 ] - Market Wire
dermaPACE Pivotal Phase III Clinical Trial Data i .. r Healing to Be Presented at Plastic Surgery 2011
[ Thu, Sep 22nd 2011 ] - Market Wire
Cambridge Heart Announces Agreement to Distribute Its HearTwave II System in Singapore
[ Thu, Sep 22nd 2011 ] - Market Wire
Columbia Laboratories Extends Stockholder Rights .. rve Use of Net Operating Losses under Section 382
[ Thu, Sep 22nd 2011 ] - Market Wire
The Future of Ablation Therapies Conference
Wed, September 21, 2011
[ Wed, Sep 21st 2011 ] - Market Wire
Less Than Two Weeks Remain before Deadline in Cla .. tion Lawsuit against Dendreon, Says Hagens Berman
[ Wed, Sep 21st 2011 ] - Market Wire
Osiris Therapeutics to Present at the Sixth Annual JMP Securities Healthcare Conference
[ Wed, Sep 21st 2011 ] - Market Wire
Health Net Announces Appearance at Credit Suisse 2nd Annual Small & Mid Cap Conference
[ Wed, Sep 21st 2011 ] - Market Wire
Alnylam to Webcast Presentation at the JMP Securities Healthcare Conference
[ Wed, Sep 21st 2011 ] - Market Wire
Ironwood Pharmaceuticals to Present at Jefferies 2011 Global Healthcare Conference
[ Wed, Sep 21st 2011 ] - Market Wire
ACADIA Pharmaceuticals to Present at the Sixth An .. ities Healthcare Conference on September 28, 2011
[ Wed, Sep 21st 2011 ] - Market Wire
Cerus to Present at Jefferies 2011 Global Healthcare Conference on Sept 28, 2011
[ Wed, Sep 21st 2011 ] - Market Wire
InSite Vision to Present at the Sixth Annual JMP Securities Healthcare Conference
[ Wed, Sep 21st 2011 ] - Market Wire
Unigene Divests Non-Core Asset and Focuses Resour .. velopment and Peptide Drug Delivery Opportunities
[ Wed, Sep 21st 2011 ] - Market Wire
ARIAD Announces Start of Enrollment in Phase 1/2 .. 3, an Investigational Dual Inhibitor of ALK and E

Investigation of Pharmaceutical Product Development by Securities Lawyers at Goldfarb Branham Law Firm LLP for Potential Shareh


//health-fitness.news-articles.net/content/2011/ .. b-branham-law-firm-llp-for-potential-shareh.html
Published in Health and Fitness on Tuesday, October 4th 2011 at 17:20 GMT by Market Wire   Print publication without navigation


Investigation of Pharmaceutical Product Development by Securities Lawyers at Goldfarb Branham Law Firm... -- DALLAS, Oct. 4, 2011 /PRNewswire/ --

Investigation of Pharmaceutical Product Development by Securities Lawyers at Goldfarb Branham Law Firm LLP for Potential Shareholder Claim Due to Buyout

[ ]

DALLAS, Oct. 4, 2011 /PRNewswire/ -- [ Goldfarb Branham LLP ] is investigating whether the board of directors of Pharmaceutical Product Development (NASDAQ: [ PPDI ]) violated shareholder protection laws by agreeing to sell the company for $33.25 per share. Concerned investors are encouraged to contact attorney Hamilton Lindley at 877-583-2855 or [ hlindley@goldfarbbranham.com ] about their rights and remedies.

"As recently as mid-August, shares of the company were trading at $32.20 per share," securities lawyer Hamilton Lindley said.  "Additionally, at least one analyst set a target price of $38.00 per share on the PPDI stock.  Our proposed shareholder class action lawsuit seeks to ensure that investors get the most value for their stock in this buyout."

[ Goldfarb Branham LLP ] lawyers have significant experience representing shareholders and whistleblowers in securities lawsuits nationwide. Pharmaceutical Product Development stockholders – or anyone with knowledge about this acquisition – should contact lawyer Hamilton Lindley at [ hlindley@goldfarbbranham.com ] or 877-583-2855.

Hamilton Lindley
Goldfarb Branham LLP
2501 N. Harwood, Ste. 1801
Dallas, TX 75201
(877) 583-2855 Toll Free Telephone
(214) 583-2233 Local Phone Number
(214) 583-2234 Fax Number
[ hlindley@goldfarbbranham.com ]
[ www.goldfarbbranham.com ]

SOURCE Goldfarb Branham LLP

[ Back to top ]

RELATED LINKS
[ http://www.goldfarbbranham.com ]


Publication Contributing Sources